Feels like big news is coming., page-7

rac could surprise the market with a big deal at any moment imho, perhaps with large back ends.

Big pharma could actually have a free go here, as they could be given a share of the spoils when that voucher is issued/sold.

That voucher alone is worth $150m, so all of a sudden rac's $5m mkt cap would look very silly indeed. One could 10x it, and it would still be very low.

That's why it's worth holding some rac in my opinion. The downside is limited to 100%, but the upside could be 100x.

And as biotech's go it's not that risky, as the drug is known to work and have some good safety properties (hence good enough for kids to use). It is even in a small trial atm.

The only negative is the lack of funds, but then a partnership wipes out that problem in a flash. fda ind could pop up soon too, making a deal even more likely imho.

cheers